129 related articles for article (PubMed ID: 6572492)
1. Biological activity of 24,24-difluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in inducing differentiation of human myeloid leukemia cells.
Shiina Y; Abe E; Miyaura C; Tanaka H; Yamada S; Ohmori M; Nakayama K; Takayama H; Matsunaga I; Nishii Y; DeLuca HF; Suda T
Arch Biochem Biophys; 1983 Jan; 220(1):90-4. PubMed ID: 6572492
[TBL] [Abstract][Full Text] [Related]
2. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
3. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
Kuribayashi T; Tanaka H; Abe E; Suda T
Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339
[TBL] [Abstract][Full Text] [Related]
4. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
Wilhelm F; Mayer E; Norman AW
Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
[TBL] [Abstract][Full Text] [Related]
5. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
6. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
7. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414
[TBL] [Abstract][Full Text] [Related]
8. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
Harada M; Miyahara T; Miyata M; Komiyama H; Sugure A; Ikemoto Y; Kondo S; Takamura T; Higuchi S; Otomo S
Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
[TBL] [Abstract][Full Text] [Related]
9. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro.
Ishizuka S; Sumitani K; Hiura K; Kawata T; Okawa M; Hakeda Y; Kumegawa M
Endocrinology; 1990 Aug; 127(2):695-701. PubMed ID: 2373050
[TBL] [Abstract][Full Text] [Related]
10. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone in the rat.
Ishizuka S; Ishimoto S; Norman AW
J Steroid Biochem; 1984 Feb; 20(2):611-5. PubMed ID: 6323873
[TBL] [Abstract][Full Text] [Related]
11. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
12. Syntheses and differentiating action of vitamin D endoperoxides. Singlet oxygen adducts of vitamin D derivatives in human myeloid leukemia cells (HL-60).
Yamada S; Yamamoto K; Naito H; Suzuki T; Ohmori M; Takayama H; Shiina Y; Miyaura C; Tanaka H; Abe E
J Med Chem; 1985 Sep; 28(9):1148-53. PubMed ID: 2993611
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of thromboxane synthesis by novel 26,27-dialkyl analogues of 1 alpha,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells.
Honda A; Mori Y; Ikekawa N; Raz A
Eur J Pharmacol; 1992 Dec; 229(2-3):217-22. PubMed ID: 1337046
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3.
Reichel H; Koeffler HP; Norman AW
Arch Biochem Biophys; 1986 Nov; 251(1):222-31. PubMed ID: 3024572
[TBL] [Abstract][Full Text] [Related]
15. Effects of diastereoisomers of 1,25-dihydroxyvitamin D3-26,23-lactone on alkaline phosphatase and collagen synthesis in osteoblastic cells.
Ishizuka S; Kiyoki M; Kurihara N; Hakeda Y; Ikeda K; Kumegawa M; Norman AW
Mol Cell Endocrinol; 1988 Jan; 55(1):77-86. PubMed ID: 2834243
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR
J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426
[TBL] [Abstract][Full Text] [Related]
17. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
18. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60).
Tanaka H; Abe E; Miyaura C; Kuribayashi T; Konno K; Nishii Y; Suda T
Biochem J; 1982 Jun; 204(3):713-9. PubMed ID: 6289803
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the differentiating action of 25-hydroxyvitamin D3 endoperoxides in human myeloid leukemia cells (HL-60).
Shiina Y; Miyaura C; Tanaka H; Abe E; Yamada S; Yamamoto K; Ino E; Takayama H; Matsunaga I; Nishii Y
J Med Chem; 1985 Sep; 28(9):1153-8. PubMed ID: 2993612
[TBL] [Abstract][Full Text] [Related]
20. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
